ASM commented on “Revisions to Payment Policies under the Physician Fee Schedule, Clinical Laboratory Fee Schedule, Access to Identifiable Data for the Center for Medicare and Medicaid Innovation Models & Other Revisions to Part B for CY 2015” as published in the July 11 Federal Register. The comments focus on proposed changes in continuing medical education (CME) and the local coverage determination (LCD) process for laboratory testing.
The National Institutes of Health (NIH) announces National Biosafety Stewardship Month
The ASM sent a statement to ASM members on Dual Use Research of Concern and Biosafety.
ASM commented on an FDA proposal to reclassify antigen based rapid influenza virus antigen detection test systems intended to detect influenza virus directly from clinical specimens.
The ASM has prepared a history related to select agents.
- July 21, 2014 - ASM Letter Regarding the Accelerating Biomedical Research Act
- July 14, 2014 - ASM Provides Comments on the Protecting Access to Medicare Act to CMS
- July 14, 2014 - Payment Determinations for Calendar Year 2015 for New Clinical Laboratory Tests
- June 16, 2014 - ASM Letter Concerning DOE Authorization Bill